Anupam Rasayan India Q2 FY27: revenue up 11.0% to ₹821 Cr, net profit up 14.0% to ₹65 Cr
Results · Finvezto · 6 Nov 2026 · Anupam Rasayan India (ANURAS)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 821 | - | +11.0% |
| Operating profit | 187 | +15.3% | +37.8% |
| Net profit | 65 | +27.0% | +14.0% |
| Operating margin | 22.8% | - | +4.4 pp |
| Net margin | 7.9% | - | +0.2 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Anupam Rasayan India reported consolidated total revenue of Rs 821 crore for Q2 FY27, up 11% YoY, with EBITDA (incl. other income) rising 41% YoY to Rs 202 crore and PAT increasing 14% YoY to Rs 65 crore. NSE filing
- During the quarter, the company completed the acquisition of a 50.07% stake in Bliss GVS Pharma and signed a six-year supply agreement with a US-based speciality metal manufacturer. NSE filing
- Revenue was ₹821 Cr, up 11.0% on a year earlier. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 24.9%, 21.6%, 24.8%, 23.2%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 61, 56, 51, 65.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.